Risks of cardiac valve regurgitation and heart failure associated with ergot-and non-ergot-derived dopamine agonist use in patients with parkinson;s disease : A systematic review of observational studies.

Tran T, Brophy JM, Suissa S, Renoux C. Risks of cardiac valve regurgitation and heart failure associated with ergot-and non-ergot-derived dopamine agonist use in patients with parkinson;s disease : A systematic review of observational studies. CNS Drugs. 2015 Dec;29(12) :985-98.

View All Publications